Tetracycline for staph
Substance |
Tetracycline |
|---|---|
Brand name: |
Tetracycline |
Description |
|
Antibiotics |
|
Tetracycline antibiotic is prescribed for infectious diseases caused by the morbific microorganisms sensitive to tetracycline |
|
Brands: |
Tetracycline |
Availability: |
Prescription needed |
Pregnancy: |
Consult a doctor |
Alcohol: |
Not detected with light alcohol consumption |
Side Effects: |
Bulging fontanel (soft spot on head) of infants |
Interactions: |
Hepatotoxicity |
Tetracycline for staph
Epidermidis strain at a frequency of. The tetracycline for staph tetracycline-inducible expression vector pALC2073 allowed high level expression of the cloned sasG gene but repression by uninduced cells was leaky. Eight (33%) of 24 tetracycline for staph patients had initially received intravenous vancomycin for a mean duration of 4. Methods: The medical records of 24 patients with serious tetracycline-susceptible MRSA infections who were treated with doxycycline or minocycline were reviewed A plasmid determining tetracycline resistance was demonstrated for Staphylococcus epidermidis. This low-level resistance to tetracycline was masked in the presence of the tetracycline plasmide but could be demonstrated after loss of the plasmid. The -10 box of the tetR promoter was mutated to the Bacillus subtitlis consensus, which resulted in complete repression of SasG protein expression Tetracyclines were administered for tetracycline for staph a mean of 89% and a median of 100% (range, 57%–100%) of the total treatment time. The results suggest that more than one mechanism of resistance to tetracyclines may exist in staphylococci. Tetracycline resistance was spontaneously lost from a S. Treatment failed for 4 patients (17%) Background: Few data exist on the efficacy of the long-acting tetracyclines doxycycline and minocycline against methicillin-resistant Staphylococcus aureus (MRSA) infection. MeSH terms Drug Resistance, Microbial* Extrachromosomal Inheritance Genes* Hot Temperature. The overall clinical success rate was 83%.